Andersons pediatric cardiology 675
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (60.67 KB, 3 trang )
echocardiographicallydeterminedleft
ventricularmassintheFraminghamHeartStudy.
NEnglJMed.1990;322(22):1561–1566.
212.MaduemePC,KhouryPR,UrbinaEM,Kimball
TR.Predictorsofexaggeratedexercise-induced
systolicbloodpressuresinyoungpatientsafter
coarctationrepair.CardiolYoung.2012;1–7.
213.GiddingSS,RocchiniAP,MooreheadC,Schork
MA,RosenthalA.Increasedforearmvascular
reactivityinpatientswithhypertensionafter
repairofcoarctation.Circulation.
1985;71(3):495–499.
214.BeekmanRH,KatzBP,Moorehead-SteffensC,
RocchiniAP.Alteredbaroreceptorfunctionin
childrenwithsystolichypertensionafter
coarctationrepair.AmJCardiol.
1983;52(1):112–117.
215.HosenpudJD,BennettLE,KeckBM,Boucek
MM,NovickRJ.TheRegistryofthe
InternationalSocietyforHeartandLung
Transplantation:seventeenthofficialreport2000.JHeartLungTransplant.
2000;19(10):909–931.
216.JohnsonDE,GaoSZ,SchroederJS,DeCampli
WM,BillinghamME.Thespectrumofcoronary
arterypathologicfindingsinhumancardiac
allografts.JHeartTransplant.1989;8(5):349–
359.
217.BenzaRL,ZoghbiGJ,TallajJ,etal.Palliationof
allograftvasculopathywithtransluminal
angioplasty:adecadeofexperience.JAmColl
Cardiol.2004;43(11):1973–1981.
218.WintersGL,KendallTJ,RadioSJ,etal.
Posttransplantobesityandhyperlipidemia:major
predictorsofseverityofcoronaryarteriopathyin
failedhumanheartallografts.JHeart
Transplant.1990;9(4):364–371.
219.BakerAM,LevineTB,GoldbergAD,Levine
AB.Naturalhistoryandpredictorsofobesity
afterorthotopichearttransplantation.JHeart
LungTransplant.1992;11(6):1156–1159.
220.WenkeK,MeiserB,ThieryJ,etal.Simvastatin
initiatedearlyafterhearttransplantation:8-year
prospectiveexperience.Circulation.
2003;107(1):93–97.
221.MahleWT,VincentRN,BergAM,KanterKR.
Pravastatintherapyisassociatedwithreduction
incoronaryallograftvasculopathyinpediatric
hearttransplantation.JHeartLungTransplant.
2005;24(1):63–66.
222.ValantineH.Cardiacallograftvasculopathyafter
hearttransplantation:riskfactorsand
management.JHeartLungTransplant.
2004;23(5suppl):S187–S193.
223.TsudaE,KamiyaT,OnoY,etal.Incidenceof
stenoticlesionspredictedbyacutephase
changesincoronaryarterialdiameterduring
Kawasakidisease.PediatrCardiol.
2005;26(1):73–79.
224.OrensteinJM,ShulmanST,FoxLM,etal.Three
linkedvasculopathicprocessescharacterize
Kawasakidisease:alightandtransmission
electronmicroscopicstudy.PLoSONE.
2012;7(6):e38998.
225.McCrindleBW,RowleyAH,NewburgerJW,et
al.Diagnosis,Treatment,andlong-term
managementofKawasakidisease:ascientific
statementforhealthprofessionalsfromthe
AmericanHeartAssociation.Circulation.
2017;135(17):e927–e999.
226.RhodesJ,CurranTJ,CamilL,etal.Sustained
effectsofcardiacrehabilitationinchildrenwith
seriouscongenitalheartdisease.Pediatrics.
2006;118(3):e586–e593.
227.RhodesJ,CurranTJ,CamilL,etal.Impactof
cardiacrehabilitationontheexercisefunctionof
childrenwithseriouscongenitalheartdisease.
Pediatrics.2005;116(6):1339–1345.
228.IemuraM,IshiiM,SugimuraT,AkagiT,Kato
H.Longtermconsequencesofregressed
coronaryaneurysmsafterKawasakidisease:
